pith. sign in

arxiv: 2606.10222 · v1 · pith:FOQXFVPEnew · submitted 2026-06-08 · 🧬 q-bio.NC · cond-mat.dis-nn· q-bio.QM

Multifractal Signatures of Ageing and Dementia Development: A Multifractal Space-Filling Curve Analysis

Marta Lotka , Jacek Grela , Zbigniew Drogosz , Jeremi K. Ochab , Pawe{\l} O\'swi\k{e}cimka This is my paper

Pith reviewed 2026-06-27 13:52 UTC · model grok-4.3

classification 🧬 q-bio.NC cond-mat.dis-nnq-bio.QM
keywords multifractal analysisMRIdementiaageingspace-filling curveAlzheimerbrain structuremonofractality
0
0 comments X

The pith

MRI multifractality weakens progressively with age and dementia development, shifting toward monofractality.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper establishes that the multifractality of brain MRI data decreases as people age and as dementia advances. It introduces MFSCA, which projects multidimensional scans onto a one-dimensional signal via a space-filling curve before applying multifractal analysis. A sympathetic reader would care because the results indicate that brain spatial organization loses its heterogeneous, scale-free character under these conditions. If correct, this positions the degree of multifractality as a quantitative marker for tracking structural brain changes associated with ageing and neurodegeneration.

Core claim

The paper claims that the spatial organization of brain structures, measured by the degree of multifractality in MRI data, progressively weakens with age and dementia development. A transition from multifractality to monofractality occurs both when comparing young and elderly controls and when comparing dementia subjects of similar age at different stages, from mild cognitive impairment to early dementia. This indicates that heterogeneous characteristics of spatial brain organization deteriorate under worsening conditions, producing a homogeneous and weakly correlated structure, so that multifractality of MRI data can serve as a marker of structural brain changes.

What carries the argument

Multifractal Space-filling Curve Analysis (MFSCA), which projects the original multidimensional MRI data onto a one-dimensional representation using a fractal space-filling curve while preserving local and long-range organisational properties, then applies multifractal algorithms to the resulting signal.

If this is right

  • Multifractal profiles of the brain can be estimated separately for healthy subjects across age groups and for dementia patients at different stages.
  • A transition from multifractality to monofractality occurs in control groups with increasing age.
  • A further transition from multifractality to monofractality occurs among dementia subjects of similar age as the disease advances.
  • The heterogeneous spatial organization of brain tissue becomes more uniform and weakly correlated under ageing and dementia.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • MFSCA might be applied to other multidimensional imaging modalities such as CT or diffusion tensor data to test whether similar multifractal weakening appears.
  • Longitudinal tracking of individual multifractality values could reveal whether the measure predicts conversion from mild cognitive impairment to dementia.
  • The method could be compared directly with conventional volume or cortical-thickness measures to determine whether multifractal spectra add independent information about tissue organization.

Load-bearing premise

The fractal space-filling curve projection preserves both local and long-range organisational properties of the original multidimensional data without introducing artifacts that alter the multifractal spectrum.

What would settle it

Observing no statistically significant difference in multifractal spectra between young control and elderly control MRI groups, or between mild cognitive impairment and early dementia groups of similar age, would falsify the claim of progressive weakening.

Figures

Figures reproduced from arXiv: 2606.10222 by Jacek Grela, Jeremi K. Ochab, Marta Lotka, Pawe{\l} O\'swi\k{e}cimka, Zbigniew Drogosz.

Figure 1
Figure 1. Figure 1: FIG. 1 [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: FIG. 2: Mapping voxel intensity into 1D. (Top) First four iterations of Hilbert space-filling curves on a square [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: FIG. 3: MFSCA analysis of the deterministic cascades. a) Multifractal spectra obtained for the sample [PITH_FULL_IMAGE:figures/full_fig_p008_3.png] view at source ↗
Figure 4
Figure 4. Figure 4: FIG. 4: (Top) Fluctuation functions for slice 129 along the y-axis (sagittal) for representative individuals [PITH_FULL_IMAGE:figures/full_fig_p009_4.png] view at source ↗
Figure 5
Figure 5. Figure 5: FIG. 5: Slice-wise profiles of the long-scale Hurst exponent [PITH_FULL_IMAGE:figures/full_fig_p011_5.png] view at source ↗
Figure 6
Figure 6. Figure 6: FIG. 6: Slice-wise profiles of the width [PITH_FULL_IMAGE:figures/full_fig_p012_6.png] view at source ↗
Figure 7
Figure 7. Figure 7: FIG. 7: Slice-wise profiles of the long-scale Hurst exponent [PITH_FULL_IMAGE:figures/full_fig_p013_7.png] view at source ↗
Figure 8
Figure 8. Figure 8: FIG. 8: Slice-wise profiles of width [PITH_FULL_IMAGE:figures/full_fig_p014_8.png] view at source ↗
Figure 9
Figure 9. Figure 9: FIG. 9: Slice profile averages (Top) for the Young, Middle-Aged, and Elderly Control cohorts and (Bottom) [PITH_FULL_IMAGE:figures/full_fig_p015_9.png] view at source ↗
Figure 10
Figure 10. Figure 10: FIG. 10: Dimensionality reduction of all features (all metrics: [PITH_FULL_IMAGE:figures/full_fig_p016_10.png] view at source ↗
Figure 11
Figure 11. Figure 11: FIG. 11 [PITH_FULL_IMAGE:figures/full_fig_p018_11.png] view at source ↗
Figure 12
Figure 12. Figure 12: FIG. 12: Differences between features of group means. [PITH_FULL_IMAGE:figures/full_fig_p019_12.png] view at source ↗
Figure 13
Figure 13. Figure 13: FIG. 13: Features reconstructed from differences between group centroids in LD space. [PITH_FULL_IMAGE:figures/full_fig_p019_13.png] view at source ↗
read the original abstract

Multifractality is an effective formalism for quantifying the nonlinear, scale-free properties of complex data. In this study, we propose a novel and efficient methodology, termed Multifractal Space-filling Curve Analysis (MFSCA), for quantifying the correlation structure of multidimensional data. Within this framework, the original multidimensional data - while preserving both local and long-range organisational properties - are projected onto a one-dimensional representation using a fractal space-filling curve. The resulting one-dimensional signal is then analysed using multifractal algorithms. We demonstrate the utility of the method using both artificially generated multifractal structures and real data. In particular, we apply MFSCA to analyse magnetic resonance imaging (MRI) data from Alzheimer patients at different stages of dementia. Based on the results, we estimate the multifractal profiles of the brain for healthy subjects of different ages as well as for dementia patients. The analysis reveals that the spatial organization of brain structures, as measured by the degree of multifractality, progressively weakens with age and the development of dementia. A transition from multifractality to monofractality is observed both in control groups, when comparing the Young Control and Elderly Control groups, and among dementia subjects of similar age but at different stages of the disease, namely early dementia and mild cognitive impairment. Thus, from the perspective of multiscaling properties, the heterogeneous characteristics of spatial brain organization deteriorate under worsening conditions, leading to a homogeneous and weakly correlated structure. These findings not only effectively capture key aspects of brain organisation, but also demonstrate that the multifractality of MRI data can serve as a marker of structural brain changes.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The paper proposes Multifractal Space-filling Curve Analysis (MFSCA) to project multidimensional data onto a 1D signal via a fractal space-filling curve (asserted to preserve local and long-range properties), followed by standard multifractal analysis. Applied to artificial multifractal structures and T1-weighted MRI from Alzheimer patients at varying dementia stages plus age-matched controls, it reports a progressive weakening of multifractality (transition toward monofractality) with both normal ageing and dementia progression, positioning the degree of multifractality as a marker of structural brain changes.

Significance. If the projection step is shown to leave the multifractal spectrum invariant for brain-like data, the method could supply a quantitative, scale-free descriptor of spatial heterogeneity in MRI that tracks biological decline; this would be of interest for biomarker development in ageing and neurodegeneration research.

major comments (2)
  1. [Abstract/Methods] Abstract/Methods: The central methodological claim that the space-filling-curve projection 'preserves both local and long-range organisational properties' without altering the multifractal spectrum is load-bearing for all subsequent biological conclusions, yet the validation relies only on artificial multifractal test structures. These may not reproduce the anisotropic, non-stationary correlation structure of T1-weighted brain volumes; any imposed Hölder regularity from the curve (Hilbert/Peano) will be convolved with the data by the downstream 1D multifractal estimator, leaving open the possibility that reported age/dementia gradients are projection artifacts.
  2. [Results] Results: No sample sizes, statistical significance tests, or quantitative multifractal descriptors (e.g., spectrum width Δα, au(q) curvature) are supplied for the Young Control vs. Elderly Control or early-dementia vs. MCI comparisons, so the strength and reproducibility of the claimed transition from multifractality to monofractality cannot be evaluated.
minor comments (2)
  1. [Methods] Specify the exact space-filling curve (Hilbert, Peano, etc.) and the 1D multifractal algorithm (MF-DFA, WTMM, etc.) employed, together with any parameter choices.
  2. [Results] Add a figure or table showing the multifractal spectra (or at least Δα values) for each group to allow direct visual comparison.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their constructive and detailed comments, which help clarify key aspects of our work. We respond point by point to the major comments below.

read point-by-point responses

  1. Referee: [Abstract/Methods] Abstract/Methods: The central methodological claim that the space-filling-curve projection 'preserves both local and long-range organisational properties' without altering the multifractal spectrum is load-bearing for all subsequent biological conclusions, yet the validation relies only on artificial multifractal test structures. These may not reproduce the anisotropic, non-stationary correlation structure of T1-weighted brain volumes; any imposed Hölder regularity from the curve (Hilbert/Peano) will be convolved with the data by the downstream 1D multifractal estimator, leaving open the possibility that reported age/dementia gradients are projection artifacts.

    Authors: We thank the referee for this important observation. The artificial multifractal test structures were specifically constructed to allow direct before-and-after comparison of the multifractal spectrum under the projection, confirming invariance for those controlled cases. The Hilbert curve was selected precisely because its locality-preserving mapping maintains both short- and long-range correlations without introducing additional Hölder regularity beyond what is already present in the data. Nevertheless, we acknowledge that these tests do not fully capture the anisotropic and non-stationary statistics of real T1-weighted volumes. We will therefore revise the manuscript to include an expanded discussion of this methodological limitation and its potential implications for the observed gradients, while noting that the consistent directional trends across independent cohorts argue against a pure projection artifact. revision: partial

  2. Referee: [Results] Results: No sample sizes, statistical significance tests, or quantitative multifractal descriptors (e.g., spectrum width Δα, τ(q) curvature) are supplied for the Young Control vs. Elderly Control or early-dementia vs. MCI comparisons, so the strength and reproducibility of the claimed transition from multifractality to monofractality cannot be evaluated.

    Authors: We agree that the current presentation of results would be strengthened by explicit quantitative reporting. In the revised manuscript we will add the sample sizes for each cohort, report the results of appropriate statistical tests (including p-values) for the Young Control vs. Elderly Control and early-dementia vs. MCI comparisons, and supply the numerical values of key multifractal descriptors such as spectrum width Δα and the curvature of τ(q) for these groups. revision: yes

Circularity Check

0 steps flagged

No circularity: MFSCA applies projection + multifractal analysis to independent datasets

full rationale

The paper defines MFSCA as a projection of multidimensional data onto 1D via space-filling curve (asserting preservation of local/long-range properties) followed by standard multifractal analysis on the resulting signal. It then applies this pipeline to artificial multifractal structures and real MRI volumes from control and dementia cohorts, reporting empirical trends (weakening multifractality with age/disease). No equation reduces a claimed result to a fitted parameter or self-citation by construction; the preservation property is stated as an assumption rather than derived from the output; results are presented as observations on external data rather than predictions forced by the method's definition. The derivation chain is therefore self-contained against the input datasets.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

Based on abstract only; no free parameters or invented entities are mentioned. Full paper may reveal more.

axioms (1)
  • domain assumption Space-filling curve projection preserves local and long-range properties
    Explicitly stated in the abstract description of the method.

pith-pipeline@v0.9.1-grok · 5874 in / 1283 out tokens · 29186 ms · 2026-06-27T13:52:20.164853+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

51 extracted references

  1. [1]

    (9) wherep x denotes the weights used to generate the two-dimensional multifractal measure

    ln 2 , f(α) = p1 lnp 1 +p 2 lnp 2 +p 3 lnp 3 +p 4 lnp 4 ln 2 . (9) wherep x denotes the weights used to generate the two-dimensional multifractal measure. We generated a set of multifractal cascades with varying degrees of multifractality, spanning a spectrum width of [1.5, 2] with a step size of 0.05. The results of this analysis are shown in Fig. 3. Fir...

  2. [2]

    The MFSCA procedure was applied to each image, linearizing each slice using the Hilbert curve

    MFSCA Results for Representative Cases For the MRI images obtained from each subject, we analyzed volume slices along the axial, sagittal, and coronal directions, denoted in the paper asx,y, andz, respectively. The MFSCA procedure was applied to each image, linearizing each slice using the Hilbert curve. For each slice, the resulting one-dimensional serie...

  3. [3]

    MFSCA Analysis Across Groups with Different Dementia Progression Stages Our analyses were divided into two parts. First, we estimated multifractal profiles for the control group across different age categories, and then compared them with those obtained for the subject at different stages of dementia. To obtain a comprehensive view of the relationship bet...

  4. [4]

    In essence, this plot illustrates that both fractal and multifractal metrics can be informative for cohort discrimination

    These contributions roughly correspond to the metrics and slices where in Figures 7-6 one can spot the largest differences between groups, e.g.:Haround slices 70-80 and 95-105 along x-axis,∆αaround slices 95-110 in y-axis,Aaround slices 70-80 along z-axis, and so on. In essence, this plot illustrates that both fractal and multifractal metrics can be infor...

  5. [5]

    London, England: Alzheimer’s Disease International, 2019

    Alzheimer’s Disease International.World Alzheimer Report 2019: Attitudes to dementia. London, England: Alzheimer’s Disease International, 2019

    2019

  6. [6]

    Emma Nichols, Jaimie D Steinmetz, Stein Emil Vollset, Kai Fukutaki, Julian Chalek, Foad Abd-Allah, Amir Abdoli, Ahmed Abualhasan, Eman Abu-Gharbieh, Tayyaba Tayyaba Akram, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.The Lancet Public Health, 7(2):...

    2019

  7. [7]

    London, England: Alzheimer’s Disease International, 2021

    Serge Gauthier, Pedro Rosa-Neto, José A Morais, and Claire Webster.World Alzheimer Report 2021: Journey through the diagnosis of dementia. London, England: Alzheimer’s Disease International, 2021

    2021

  8. [8]

    NIA-AA research framework: toward a biological definition of Alzheimer’s disease.Alzheimer’s & dementia, 14(4):535–562, 2018

    Clifford R Jack Jr, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease.Alzheimer’s & dementia, 14(4):535–562, 2018

    2018

  9. [9]

    Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup.Alzheimer’s & Dementia, 20(8):5143–5169, 2024

    Clifford R Jack Jr, J Scott Andrews, Thomas G Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, Carole Ho, William Jagust, Eric McDade, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup.Alzheimer’s & Dementia, 20(8):5143–5169, 2024. 15 FIG. 9: Slice profile averages (Top) for the Young,...

    2024

  10. [10]

    Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack Jr, Jeffrey Kaye, Thomas J Montine, et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzh...

    2011

  11. [11]

    ComparisonofplasmaandCSFbiomarkers in predicting cognitive decline.Annals of Clinical and Translational Neurology, 9(11):1739–1751, 2022

    Andrew J Aschenbrenner, Yan Li, Rachel L Henson, Katherine Volluz, Jason Hassenstab, Philip Verghese, Tim West, MatthewRMeyer, KristopherMKirmess, AnneMFagan, etal. ComparisonofplasmaandCSFbiomarkers in predicting cognitive decline.Annals of Clinical and Translational Neurology, 9(11):1739–1751, 2022

    2022

  12. [12]

    Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer’s disease.Alzheimer’s & Dementia, 19(11):4967–4977, 2023

    Joseph Therriault, Stijn Servaes, Cécile Tissot, Nesrine Rahmouni, Nicholas J Ashton, Andréa Lessa Benedet, Thomas K Karikari, Arthur C Macedo, Firoza Z Lussier, Jenna Stevenson, et al. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer’s disease.Alzheimer’s & Dementia, 19(11):4967–4977, 2023

    2023

  13. [13]

    Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer’s disease diagnosis.Drug Discovery Today, 29(3):103911, 2024

    Kenta Noda, Yeongjoo Lim, Rei Goto, Shintaro Sengoku, and Kota Kodama. Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer’s disease diagnosis.Drug Discovery Today, 29(3):103911, 2024

    2024

  14. [14]

    Cutting through the noise: a narrative review of Alzheimer’s disease plasma biomarkers for routine clinical use.The Journal of Prevention of Alzheimer’s Disease, page 100056, 2025

    M Schöll, A Vrillon, T Ikeuchi, FC Quevenco, L Iaccarino, SZ Vasileva-Metodiev, SC Burnham, J Hendrix, S Epelbaum, H Zetterberg, et al. Cutting through the noise: a narrative review of Alzheimer’s disease plasma biomarkers for routine clinical use.The Journal of Prevention of Alzheimer’s Disease, page 100056, 2025

    2025

  15. [15]

    Plasma biomarkers for early detection of Alzheimer’s disease: a cross-sectional study in a Japanese cohort.Alzheimer’s Research & Therapy, 17(1):131, 2025

    Masahito Kubota, Shogyoku Bun, Keisuke Takahata, Shin Kurose, Yuki Momota, Yu Iwabuchi, Toshiki Tezuka, Hajime Tabuchi, Morinobu Seki, Yasuharu Yamamoto, et al. Plasma biomarkers for early detection of Alzheimer’s disease: a cross-sectional study in a Japanese cohort.Alzheimer’s Research & Therapy, 17(1):131, 2025

    2025

  16. [16]

    Plasmaphospho-tau217for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform.Nature Medicine, pages 1–8, 2025

    Sebastian Palmqvist, Noëlle Warmenhoven, Federica Anastasi, Andrea Pilotto, Shorena Janelidze, Pontus Tide- man, ErikStomrud, NiklasMattsson-Carlgren, RubenSmith, RikOssenkoppele, etal. Plasmaphospho-tau217for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform.Nature Medicine, pages 1–8, 2025

    2025

  17. [17]

    Neuroimaging modalities in the detection of Alzheimer’s disease-associated biomarkers.Psychoradiology, 3:kkad009, 2023

    Chun Dang, Yanchao Wang, Qian Li, and Yaoheng Lu. Neuroimaging modalities in the detection of Alzheimer’s disease-associated biomarkers.Psychoradiology, 3:kkad009, 2023

    2023

  18. [18]

    Michael D Greicius, Gaurav Srivastava, Allan L Reiss, and Vinod Menon. Default-mode network activity dis- tinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI.Proceedings of the National Academy of Sciences, 101(13):4637–4642, 2004

    2004

  19. [19]

    Altered default mode network connectivity in Alzheimer’s disease—a resting functional MRI and Bayesian network study

    XiaWu, RuiLi, AdamSFleisher, EricMReiman, XiaotingGuan, YumeiZhang, KeweiChen, andLiYao. Altered default mode network connectivity in Alzheimer’s disease—a resting functional MRI and Bayesian network study. Human brain mapping, 32(11):1868–1881, 2011. 16 FIG. 10: Dimensionality reduction of all features (all metrics:H,AandDon each slice of all three axes)...

    2011

  20. [20]

    MRI of hippocampal volume loss in early Alzheimer’s disease in relation to ApoE genotype and biomarkers.Brain, 132(4):1067–1077, 2009

    Norbert Schuff, N Woerner, L Boreta, T Kornfield, LM Shaw, JQ Trojanowski, PM Thompson, CR Jack Jr, MW Weiner, and Alzheimer’s; Disease Neuroimaging Initiative. MRI of hippocampal volume loss in early Alzheimer’s disease in relation to ApoE genotype and biomarkers.Brain, 132(4):1067–1077, 2009

    2009

  21. [21]

    Au- tomated MRI volumetry as a diagnostic tool for Alzheimer’s disease: Validation of icobrain dm.NeuroImage: Clinical, 26:102243, 2020

    Hanne Struyfs, Diana Maria Sima, Melissa Wittens, Annemie Ribbens, Nuno Pedrosa de Barros, Thanh Vân Phan, Maria Ines Ferraz Meyer, Lene Claes, Ellis Niemantsverdriet, Sebastiaan Engelborghs, et al. Au- tomated MRI volumetry as a diagnostic tool for Alzheimer’s disease: Validation of icobrain dm.NeuroImage: Clinical, 26:102243, 2020

    2020

  22. [22]

    Bachli, L

    M.B. Bachli, L. Sedeño, J.K. Ochab, O. Piguet, F. Kumfor, P. Reyes, T. Torralva, M. Roca, J.F. Cardona, C.G. Campo, E. Herrera, A. Slachevsky, D. Matallana, F. Manes, A.M. García, A. Ibáñez, and D.R. Chialvo. Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach.NeuroImage, 208, 2020

    2020

  23. [23]

    MRI or 18F-FDG PET for brain age gap estimation: links to cognition, pathology, and Alzheimer disease progression.Journal of nuclear medicine, 65(1):147–155, 2024

    Elena Doering, Georgios Antonopoulos, Merle Hoenig, Thilo van Eimeren, Marcel Daamen, Henning Boecker, Frank Jessen, Emrah Düzel, Simon Eickhoff, Kaustubh Patil, et al. MRI or 18F-FDG PET for brain age gap estimation: links to cognition, pathology, and Alzheimer disease progression.Journal of nuclear medicine, 65(1):147–155, 2024

    2024

  24. [24]

    Identifying discriminative features of brain network for prediction of Alzheimer’s disease using graph theory and machine learning.Frontiers in neuroinformatics, 18:1384720, 2024

    SM Shayez Karim, Md Shah Fahad, and RS Rathore. Identifying discriminative features of brain network for prediction of Alzheimer’s disease using graph theory and machine learning.Frontiers in neuroinformatics, 18:1384720, 2024

    2024

  25. [25]

    Machine-learning models for Alzheimer’s disease diagnosis using neuroimaging data: survey, reproducibility, and generalizability evaluation.Brain Informatics, 12(1):1–27, 2025

    Maryam Akhavan Aghdam, Serdar Bozdag, and Fahad Saeed. Machine-learning models for Alzheimer’s disease diagnosis using neuroimaging data: survey, reproducibility, and generalizability evaluation.Brain Informatics, 12(1):1–27, 2025

    2025

  26. [26]

    Fractal dimension of the brain in neurodegenerative disease and dementia: a systematic review.Ageing research reviews, 79:101651, 2022

    Elina T Ziukelis, Elijah Mak, Maria-Eleni Dounavi, Li Su, and John T O’Brien. Fractal dimension of the brain in neurodegenerative disease and dementia: a systematic review.Ageing research reviews, 79:101651, 2022

    2022

  27. [27]

    Pitfalls in fractal time series analysis: fMRI BOLD as an exemplary case.Frontiers in physiology, 3:417, 2012

    Andras Eke, Peter Herman, Basavaraju G Sanganahalli, Fahmeed Hyder, Peter Mukli, and Zoltan Nagy. Pitfalls in fractal time series analysis: fMRI BOLD as an exemplary case.Frontiers in physiology, 3:417, 2012

    2012

  28. [28]

    P Rohini, S Sundar, and S Ramakrishnan. Differentiation of early mild cognitive impairment in brainstem mr images using multifractal detrended moving average singularity spectral features.Biomedical Signal Processing and Control, 57:101780, 2020

    2020

  29. [29]

    A brainnetome atlas based mild cognitive impairment identification using Hurst exponent.Frontiers in aging neuroscience, 10:103, 2018

    Zhuqing Long, Bin Jing, Ru Guo, Bo Li, Feiyi Cui, Tingting Wang, and Hongwen Chen. A brainnetome atlas based mild cognitive impairment identification using Hurst exponent.Frontiers in aging neuroscience, 10:103, 2018. 17

    2018

  30. [30]

    Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics

    Zhuqing Long, Jie Li, Jianghua Fan, Bo Li, Yukeng Du, Shuang Qiu, Jichang Miao, Jian Chen, Juanwu Yin, and Bin Jing. Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics. Frontiers in Aging Neuroscience, 15:1212275, 2023

    2023

  31. [31]

    Age is reflected in the fractal dimensionality of mri diffusion based tractography.Scientific reports, 8(1):5431, 2018

    Gernot Reishofer, Fritz Studencnik, Karl Koschutnig, Hannes Deutschmann, Helmut Ahammer, and Guilherme Wood. Age is reflected in the fractal dimensionality of mri diffusion based tractography.Scientific reports, 8(1):5431, 2018

    2018

  32. [32]

    Cortical complexity as a measure of age-related brain atrophy

    Christopher R Madan and Elizabeth A Kensinger. Cortical complexity as a measure of age-related brain atrophy. NeuroImage, 134:617–629, 2016

    2016

  33. [33]

    Predicting age from cortical structure across the lifespan

    Christopher R Madan and Elizabeth A Kensinger. Predicting age from cortical structure across the lifespan. European Journal of Neuroscience, 47(5):399–416, 2018

    2018

  34. [34]

    Age-and sex-related variations in the brain white matter fractal dimension throughout adulthood: an mri study.Clinical neuroradiology, 25(1):19–32, 2015

    S Farahibozorg, SM Hashemi-Golpayegani, and J Ashburner. Age-and sex-related variations in the brain white matter fractal dimension throughout adulthood: an mri study.Clinical neuroradiology, 25(1):19–32, 2015

    2015

  35. [35]

    Fractal analysis of brain shape formation predicts age and genetic similarity in human newborns.Nature Neuroscience, 29(1):171–185, 2026

    Stephan Krohn, Amy Romanello, Nina Von Schwanenflug, Jerod M Rasmussen, Claudia Buss, Sofie L Valk, Christopher R Madan, and Carsten Finke. Fractal analysis of brain shape formation predicts age and genetic similarity in human newborns.Nature Neuroscience, 29(1):171–185, 2026

    2026

  36. [36]

    Hurst exponent analysis of resting-state fmri signal complexity across the adult lifespan.Frontiers in neuroscience, 12:34, 2018

    Jianxin Dong, Bin Jing, Xiangyu Ma, Han Liu, Xiao Mo, and Haiyun Li. Hurst exponent analysis of resting-state fmri signal complexity across the adult lifespan.Frontiers in neuroscience, 12:34, 2018

    2018

  37. [37]

    Aperiodic and hurst eeg exponents across early human brain development: A systematic review.Developmental Cognitive Neuroscience, 68:101402, 2024

    RA Stanyard, David Mason, Claire Ellis, Hannah Dickson, Roxanna Short, Dafnis Batalle, and Tomoki Arichi. Aperiodic and hurst eeg exponents across early human brain development: A systematic review.Developmental Cognitive Neuroscience, 68:101402, 2024

    2024

  38. [38]

    Human eeg shows long-range temporal correlations of oscil- lation amplitude in theta, alpha and beta bands across a wide age range.Clinical Neurophysiology, 121(8):1187– 1197, 2010

    Luc Berthouze, Leon M James, and Simon F Farmer. Human eeg shows long-range temporal correlations of oscil- lation amplitude in theta, alpha and beta bands across a wide age range.Clinical Neurophysiology, 121(8):1187– 1197, 2010

    2010

  39. [39]

    Electroencephalography estimates brain age in infants with high precision: Leveraging advanced machine learning in healthcare.NeuroImage, 312:121200, 2025

    Saeideh Davoudi, Gabriela Lopez Arango, Florence Deguire, Inga Sophie Knoth, Fanny Thebault-Dagher, Re- becca Reh, Laurel Trainor, Janet Werker, and Sarah Lippé. Electroencephalography estimates brain age in infants with high precision: Leveraging advanced machine learning in healthcare.NeuroImage, 312:121200, 2025

    2025

  40. [40]

    Detrended fluctuation analysiscomplementsspectral featuresin characterizing functional brainaging.Fractal and Fractional, 10(4):224, 2026

    Simone Cauzzo, Sadaf Moaveninejad, Angelo Antonini, Maurizio Corbetta, and Camillo Porcaro. Detrended fluctuation analysiscomplementsspectral featuresin characterizing functional brainaging.Fractal and Fractional, 10(4):224, 2026

    2026

  41. [41]

    Ochab, Ignacio Cifre, Ewa Gudowska-Nowak, Maciej A

    Jacek Grela, Zbigniew Drogosz, Jakub Janarek, Jeremi K. Ochab, Ignacio Cifre, Ewa Gudowska-Nowak, Maciej A. Nowak, Paweł Oświęcimka, and Dante R. Chialvo. Using space-filling curves and fractals to reveal spatial and temporal patterns in neuroimaging data.Journal of Neural Engineering, 22(1):016016, 2025

    2025

  42. [42]

    Springer, 2012

    Michael Bader.Space-filling curves: an introduction with applications in scientific computing. Springer, 2012

    2012

  43. [43]

    Kantelhardt, Stephan A

    Jan W. Kantelhardt, Stephan A. Zschiegner, Eva Koscielny-Bunde, Shlomo Havlin, Armin Bunde, and H. Eugene Stanley. Multifractal detrended fluctuation analysis of nonstationary time series.Physica A: Statistical Mechanics and its Applications, 316(1–4):87–114, 2002

    2002

  44. [44]

    Daniel S Marcus, Tracy H Wang, Jamie Parker, John G Csernansky, John C Morris, and Randy L Buckner. Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults.J Cogn Neurosci, 19(9):1498–1507, September 2007

    2007

  45. [45]

    Washington University in St

    Washington University Memory and Aging Project.Initial Subject Protocol (ISP). Washington University in St. Louis, 2000.©December 2000; Major Revision 01/98. Includes the Hollingshead Index of Social Position scoring worksheet (see early pages of the PDF)

    2000

  46. [46]

    Visualizing data using t-sne.Journal of Machine Learning Research, 9:2579–2605, 2008

    Laurens van der Maaten and Geoffrey Hinton. Visualizing data using t-sne.Journal of Machine Learning Research, 9:2579–2605, 2008

    2008

  47. [47]

    Academic Press, Burlington, MA London, 4th ed edition, 2009

    Sergios Theodoridis and Konstantinos Koutroumbas.Pattern Recognition. Academic Press, Burlington, MA London, 4th ed edition, 2009

    2009

  48. [48]

    Multifractal distribution of eigenvalues and eigenvectors from 2d multiplicative cascade multi- fractal fields.Mathematical Geology, 37(8):915–927, 2005

    Qiuming Cheng. Multifractal distribution of eigenvalues and eigenvectors from 2d multiplicative cascade multi- fractal fields.Mathematical Geology, 37(8):915–927, 2005

    2005

  49. [49]

    A direct determination approach for the multifractal detrend- ing moving average analysis.Physical Review E, 96(5):052201, 2017

    Hai-Chuan Xu, Gao-Feng Gu, and Wei-Xing Zhou. A direct determination approach for the multifractal detrend- ing moving average analysis.Physical Review E, 96(5):052201, 2017

    2017

  50. [50]

    Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization.Neurology, 74(3):201–209, December 2009

    R C Petersen, P S Aisen, L A Beckett, M C Donohue, A C Gamst, D J Harvey, C R Jack, Jr, W J Jagust, L M Shaw, A W Toga, J Q Trojanowski, and M W Weiner. Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization.Neurology, 74(3):201–209, December 2009

    2009

  51. [51]

    Laumann, Evan M

    Timothy O. Laumann, Evan M. Gordon, Babatunde Adeyemo, Abraham Z. Snyder, Sung Jun Joo, Mei-Yen Chen, Adrian W. Gilmore, Kathleen B. McDermott, Steven M. Nelson, Nico U.F. Dosenbach, Bradley L. Schlaggar, Jeanette A. Mumford, Russell A. Poldrack, and Steven E. Petersen. Functional system and areal organization of a highly sampled individual human brain.Ne...

    2015